Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
CONCLUSION: The highest strength of supporting evidence is for the recommendation of biologic agents including tumor necrosis factor inhibitors, and interleukin 12/23, 17, and 23 inhibitors.PMID:36319021 | DOI:10.3899/jrheum.220313
Source: Journal of Rheumatology - Category: Rheumatology Authors: Dhruvkumar Laheru Anna Antony Sueli Carneiro Vito Di Lernia Amit Garg Thorvardur Jon Love Karla Del Rocio Macias Garcia Jos é Alexandre Mendonça Sandeep Mukherjee Rodica Olteanu Lourdes Perez-Chada Cheryl F Rosen Rachel Tannenbaum Michel Alexandre Yazbe Source Type: research
More News: Acitretin | Arthritis | Corticosteroid Therapy | Databases & Libraries | Dermatology | Men | Methotrexate | Prograf | Psoriasis | Psoriatic Arthritis | Restasis | Rheumatology | Skin | Taclonex | Tacrolimus